相似文献
1
N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
J Med Chem. 2003 Aug 28;46(18):3775-7. doi: 10.1021/jm034098e.
2
Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
Bioorg Med Chem. 2006 Jul 15;14(14):4718-30. doi: 10.1016/j.bmc.2006.03.030. Epub 2006 Apr 5.
3
D-4'-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor.
Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):607-9. doi: 10.1081/NCN-200061827.
4
Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor.
Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1565-8. doi: 10.1080/15257770701547107.
5
Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
Bioorg Med Chem. 2009 Dec 1;17(23):8003-11. doi: 10.1016/j.bmc.2009.10.011. Epub 2009 Oct 12.
6
Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
J Med Chem. 2007 Jul 12;50(14):3159-62. doi: 10.1021/jm070259t. Epub 2007 Jun 8.
7
Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Bioorg Med Chem. 2009 May 15;17(10):3733-8. doi: 10.1016/j.bmc.2009.03.034. Epub 2009 Mar 25.
8
Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands.
Bioorg Med Chem Lett. 2003 Mar 10;13(5):817-20. doi: 10.1016/s0960-894x(03)00027-1.
9
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
J Med Chem. 2008 Oct 23;51(20):6609-13. doi: 10.1021/jm8008647. Epub 2008 Sep 24.
10
Development of potent and selective human A3 adenosine receptor agonists.
Nucleic Acids Symp Ser (Oxf). 2005(49):31-2. doi: 10.1093/nass/49.1.31.
引用本文的文献
1
Therapeutic potential of adenosine receptor modulators in cancer treatment.
RSC Adv. 2025 Jun 17;15(26):20418-20445. doi: 10.1039/d5ra02235e. eCollection 2025 Jun 16.
2
Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A Adenosine Receptor Ligands.
ACS Med Chem Lett. 2025 Apr 2;16(5):880-886. doi: 10.1021/acsmedchemlett.5c00138. eCollection 2025 May 8.
3
Synthesis and Biological Evaluation of 5'-Deoxy-adenosine Derivatives as A Adenosine Receptor Ligands.
ACS Med Chem Lett. 2024 Dec 11;16(1):149-156. doi: 10.1021/acsmedchemlett.4c00522. eCollection 2025 Jan 9.
4
Structure-Activity Relationship of Truncated 4'-Selenonucleosides: A Adenosine Receptor Activity and Binding Selectivity.
ACS Med Chem Lett. 2024 Aug 22;15(9):1620-1626. doi: 10.1021/acsmedchemlett.4c00344. eCollection 2024 Sep 12.
5
Structure-Activity Relationship of Truncated 2,8-Disubstituted-Adenosine Derivatives as Dual A/A Adenosine Receptor Antagonists and Their Cancer Immunotherapeutic Activity.
J Med Chem. 2023 Sep 14;66(17):12249-12265. doi: 10.1021/acs.jmedchem.3c00806. Epub 2023 Aug 21.
6
Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary.
J Med Chem. 2021 Sep 9;64(17):12525-12536. doi: 10.1021/acs.jmedchem.1c00239. Epub 2021 Aug 26.
7
Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.
Mol Divers. 2022 Jun;26(3):1779-1821. doi: 10.1007/s11030-021-10257-9. Epub 2021 Jun 27.
8
When nucleoside chemistry met hypervalent iodine reagents.
ARKIVOC. 2018;2018(Pt II):252-279. doi: 10.24820/ark.5550190.p010.281. Epub 2017 Dec 21.
9
N-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation.
J Med Chem. 2017 Apr 27;60(8):3422-3437. doi: 10.1021/acs.jmedchem.7b00241. Epub 2017 Apr 19.
10
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.
J Med Chem. 2014 Feb 27;57(4):1344-54. doi: 10.1021/jm4015313. Epub 2014 Feb 5.
本文引用的文献
1
N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
Biochem Pharmacol. 2003 May 15;65(10):1675-84. doi: 10.1016/s0006-2952(03)00153-9.
2
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
J Med Chem. 2002 Sep 26;45(20):4471-84. doi: 10.1021/jm020211+.
3
N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
J Med Chem. 2002 Jul 18;45(15):3271-9. doi: 10.1021/jm0109762.
4
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Oncogene. 2002 Jun 6;21(25):4060-4. doi: 10.1038/sj.onc.1205531.
5
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.
Annu Rev Pharmacol Toxicol. 2001;41:775-87. doi: 10.1146/annurev.pharmtox.41.1.775.
6
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
J Med Chem. 2000 Jun 1;43(11):2196-203. doi: 10.1021/jm9905965.
7
A(3) adenosine receptor ligands: history and perspectives.
Med Res Rev. 2000 Mar;20(2):103-28. doi: 10.1002/(sici)1098-1128(200003)20:2<103::aid-med1>3.0.co;2-x.
8
The role of receptor structure in determining adenosine receptor activity.
Pharmacol Ther. 2000 Feb;85(2):55-75. doi: 10.1016/s0163-7258(99)00051-0.
9
Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
Ann N Y Acad Sci. 1999;890:93-106. doi: 10.1111/j.1749-6632.1999.tb07984.x.
10
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.
J Biol Chem. 2000 Feb 11;275(6):4429-34. doi: 10.1074/jbc.275.6.4429.
Zotero 插件